申请人:Nikken Chemicals Company, Limited
公开号:EP1044974A1
公开(公告)日:2000-10-18
A novel N-hydroxyurea derivative represented by formula (I) and having antiallergic and anti-inflammatory effects, i.e., N-hydroxy-N-[6-(3-pyridylmethyl)-2H-1-benzopyran-3-ylmethyl]urea:
and medicines containing the above urea derivative or a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof as the active ingredient, particularly antiallergic or anti-inflammatory agent, especially antiasthmatic.
一种由式(I)代表并具有抗过敏和抗炎作用的新型 N-羟基脲衍生物,即 N-羟基-N-[6-(3-吡啶基甲基)-2H-1-苯并吡喃-3-基甲基]脲:
以及含有上述脲衍生物或其药理学上可接受的盐、或其水合物或溶液作为活性成分的药物,特别是抗过敏或消炎药,尤其是抗哮喘药。